Bovie Medical seeks FDA marketing approval for new laparoscopic instruments

By E. Janene Geiss

Philadelphia, Aug. 22 - Bovie Medical Corp. announced Tuesday the filing of a 510(k) application for a new line of patent-pending advanced modular laparoscopic electrosurgical electrodes and handle aimed at the laparoscopic and arthroscopic markets.

The Modular Ergonomic Instruments (MEG) family is an innovative advancement of current hand instruments used in electrosurgery, the company said in a news release.

The MEG line combined with the company's advanced electrosurgical generators offers users cost savings as well as reduced and simplified inventory, Bovie said.

The reusable, insulated MEG line handle comes with light metallic grips, transparent ratchet and ergonomic design, which should reduce surgeon fatigue and improve tactile feel, officials added. The handle accepts reusable tip inserts that are simple with minimal-required user training.

Commercial prototypes have been developed and Bovie said it plans to begin marketing after necessary clearance from the FDA.

It has been estimated that the total annual worldwide market for this product line exceeds $200 million, the company said.

Bovie Medical is a Melville, N.Y., maker of medical technologies and products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.